These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 28432271

  • 1. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
    Xu J, Zhang S, Wang R, Wu X, Zeng L, Fu Z.
    Biosci Rep; 2017 Jun 30; 37(3):. PubMed ID: 28432271
    [Abstract] [Full Text] [Related]

  • 2. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
    Wang R, Wei J, Zhang S, Wu X, Guo J, Liu M, Du K, Xu J, Peng L, Lv Z, You W, Xiong Y, Fu Z.
    Oncotarget; 2016 Dec 27; 7(52):86816-86828. PubMed ID: 27894099
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L.
    Mol Carcinog; 2017 Dec 27; 56(12):2669-2680. PubMed ID: 28767179
    [Abstract] [Full Text] [Related]

  • 4. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
    Gao Y, Xiao X, Zhang C, Yu W, Guo W, Zhang Z, Li Z, Feng X, Hao J, Zhang K, Xiao B, Chen M, Huang W, Xiong S, Wu X, Deng W.
    J Pineal Res; 2017 Mar 27; 62(2):. PubMed ID: 27865009
    [Abstract] [Full Text] [Related]

  • 5. Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Zhang B, Leng C, Wu C, Zhang Z, Dou L, Luo X, Zhang B, Chen X.
    Oncol Rep; 2016 Mar 27; 35(3):1807-15. PubMed ID: 26647806
    [Abstract] [Full Text] [Related]

  • 6. The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells.
    Kugimiya N, Nishimoto A, Hosoyama T, Ueno K, Enoki T, Li TS, Hamano K.
    J Cell Mol Med; 2015 Jul 27; 19(7):1569-81. PubMed ID: 25689483
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J, Dong W, Xie C, Wang L, Han DL, Wang S, Guo HL, Zhang ZL.
    IUBMB Life; 2015 Mar 27; 67(3):191-201. PubMed ID: 25873402
    [Abstract] [Full Text] [Related]

  • 8. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S, Tian J, Zhang H, Zhou S, Wang X, Zhang L, Yang J, Zhang Z, Ji Z.
    Apoptosis; 2018 Jun 27; 23(5-6):356-374. PubMed ID: 29777330
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer.
    Zhang Y, Talmon G, Wang J.
    Cell Death Dis; 2015 Aug 06; 6(8):e1845. PubMed ID: 26247730
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
    Shang J, Yang F, Wang Y, Wang Y, Xue G, Mei Q, Wang F, Sun S.
    J Cell Biochem; 2014 Apr 06; 115(4):772-84. PubMed ID: 24249161
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
    Yu S, Wu C, Tan Q, Liu H.
    J Cell Biochem; 2019 Sep 06; 120(9):15131-15144. PubMed ID: 31020694
    [Abstract] [Full Text] [Related]

  • 12. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T, Wu X, Li Y, Lu W, Zheng F, Zhang C, Long Q, Qiu H, Li Y, Ge Q, Chen M, Yu X, Chen W, Zhang H, Huang W, Luo M, Deng W, Li L.
    Cell Physiol Biochem; 2018 Sep 06; 46(4):1365-1380. PubMed ID: 29689552
    [Abstract] [Full Text] [Related]

  • 13. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
    Liu Y, Bi T, Wang Z, Wu G, Qian L, Gao Q, Shen G.
    Apoptosis; 2016 Dec 06; 21(12):1398-1407. PubMed ID: 27671687
    [Abstract] [Full Text] [Related]

  • 14. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y, Zhang M, Zhang Z, Jia Y, Zhang C, Peng L.
    Biomed Pharmacother; 2020 Sep 06; 129():109851. PubMed ID: 32559627
    [Abstract] [Full Text] [Related]

  • 15. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY, Lee JS, Min HY, Lee HY.
    Oncotarget; 2015 Oct 20; 6(32):32622-33. PubMed ID: 26416450
    [Abstract] [Full Text] [Related]

  • 16. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
    Lin J, Feng J, Yang H, Yan Z, Li Q, Wei L, Lai Z, Jin Y, Peng J.
    Oncol Rep; 2017 Oct 20; 38(4):2293-2300. PubMed ID: 28849113
    [Abstract] [Full Text] [Related]

  • 17. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM, Simões AE, Gomes SE, Castro RE, Carvalho T, Rodrigues CM, Borralho PM.
    Oncotarget; 2016 Jun 07; 7(23):34322-40. PubMed ID: 27144434
    [Abstract] [Full Text] [Related]

  • 18. Enhanced in vitro tumoricidal effects of 5-Fluorouracil, thymoquinone, and active vitamin D3 triple therapy against colon cancer cells by attenuating the PI3K/AKT/mTOR pathway.
    Idris S, Refaat B, Almaimani RA, Ahmed HG, Ahmad J, Alhadrami M, El-Readi MZ, Elzubier ME, Alaufi HAA, Al-Amin B, Alghamdi AA, Bahwerth F, Minshawi F, Kabrah SM, Aslam A.
    Life Sci; 2022 May 01; 296():120442. PubMed ID: 35245520
    [Abstract] [Full Text] [Related]

  • 19. Ginsenoside Rg3 enhances the anticancer effect of 5‑FU in colon cancer cells via the PI3K/AKT pathway.
    Hong S, Cai W, Huang Z, Wang Y, Mi X, Huang Y, Lin Z, Chen X.
    Oncol Rep; 2020 Oct 01; 44(4):1333-1342. PubMed ID: 32945504
    [Abstract] [Full Text] [Related]

  • 20. ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells.
    Wang X, Wang Y, Gu J, Zhou D, He Z, Wang X, Ferrone S.
    Sci Rep; 2017 Aug 29; 7(1):9687. PubMed ID: 28852196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.